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18th March, 2016 
Endocrinology 
2055 L Street NW, Suite 600 
Washington, DC 20036 
 
Dear Dr Hugh Taylor, 
 On behalf of my colleagues, thank you very much for the review of our manuscript entitled 
Cyclical DNA methyltransferase 3a expression is a seasonal and oestrus timer in reproductive 
tissues (EN-15-1988). We were pleased to read the positive response and the potential for 
publication in Endocrinology. We appreciate the constructive feedback from all three Reviewers 
and accordingly, we have thoroughly revised the manuscript. In the response to reviewer document, 
we have enumerated each reviewer comment and provide a detailed response. We feel the 
comments from the Reviewers have resulted in a much stronger manuscript. In brief, the major 
revisions in the manuscript include: 
1) In response to Reviewer 1, we have completely revised the abstract and results according to 
their suggestion to separate testicular and ovarian analyses. 
2) In addition to the preadsorption suggested by Reviewer 1, we have also conducted three 
negative control immunocytochemistry assays. All confirm the specificity of the DNMT3a 
antibody. 
3) In response to Reviewer 2, we have conducted qPCR for a second reference gene, ribosomal 
18s (18s). The revised analyses do not significantly change the findings or implications of 
the data compared to the initial submission. 
4) Moreover, we have provided the uterine histology as requested by Reviewer 2 (see new 
Figure S3). The histology confirms that DNMT3a expression is primarily localized in the 
endometrium. 
5) In response to Reviewer 3 we have conducted a hematoxylin and eosin stain on testicular 
tissue (new FigS2) as well as uterine tissue (FigS3). This stain provided the ability to 
confirm that DNMT3a is primarily localized to the spermatogonium in SD testes. 
In addition, we have incorporated a series of minor revisions indicated by the Reviewers. 
Unfortunately, I am unable to accommodate the request by Reviewer 3 for an alternative method to 
examine global DNA methylation. Other techniques to confirm DNA methylation include 
chromatin-immunoprecipitation or sodium bisulfite conversion of DNA. Both of these approaches 
include bioinformatic analyses that are not financial feasible. 
Thank you in advance for considering our revised manuscript for publication and we look 
forward to your response. 
 
Sincerely, 
 
Tyler John Stevenson, Ph.D. 
Institute of Biological and Environmental Sciences 
University of Aberdeen 
School of Biological Sciences 
Zoology Building 
Tillydrone Avenue 
Aberdeen AB24 2TZ 
Scotland 
United Kingdom 
Tel: +44 (0) 1224 274144 
Cover Letter
General response: 
We thank the reviewers for the objective and careful assessment of our manuscript. Below, we have 
enumerated each comment and provided a detailed response. We have endeavoured to incorporate 
each suggestion in the revised manuscript. There have been four major revisions: 
1) The results have been revised using the average CT of 2 reference genes 
2) We have conducted a hematoxylin and eosin stain on testicular tissue (new FigS2) 
3) We have revised the statistical analyses and examined testicular and ovarian tissue 
separately. 
4) We have conducted histological analyses on the uterine tissue to confirm DNMT3a 
expression is localized in the endometrium. 
 
Reviewer #1:  
Comment 1 - The abstract and results sections might benefit from a re-organization by sex.  The 
comparison between testicular and ovarian methylation/dnmt expression is somewhat specious as it 
is unusual compare gene expression across tissues. The same holds true for comparison of testicular 
and ovarian mass by ANOVA as the magnitude of weight difference will differ by tissue. My 
suggestion would be to organize the abstract and results sections to discuss testicular 
methylation/dnmt expression and the testicular IHC results together.  Then, discuss ovarian and 
uterine results, including those that point to hormonal changes contributing to seasonal changes.  
Conclude with the suggestion that melatonin might drive changes in both sexes based on the 
HEK293 cell culture work. 
Response 1 – We agree with the Reviewers suggestion to reorganize the abstract and results section. 
We have revised both sections accordingly. Now, the abstract and result sections have been divided 
by sex and then followed by hormonal analyses in ovariectomized hamsters and HEK293 cells. We 
have also divided the male and female gonad data into two separate figures (new Fig1 and Fig2). 
 
Comment 2 - The abstract is packed with a listing of findings without transitional elements to the 
sentences to highlight the impetus for the findings or their significance.  The abstract might benefit 
from some consolidation of major findings and the addition of such transitional/supporting 
language.  
Response 2 – We have considerably revised the abstract taking into consideration the suggestions 
raised in Comment 1 above. During the revision we endeavoured to include transitional language to 
consolidate the major findings. 
 
Comment 3 - 9000 RPMs seems unusually high for spinning blood samples and has the potential to 
lyse RBCs.  Is this a typo? 
Response 3 – The plasma was centrifuged at 9000rpms. Indeed the speed has a significant impact 
on the ability to separate supernatant from RBCs; however the major impact is the diameter of the 
centrifuge. The important value is the g-force (indicated in the methods as 3622g) and is calculated 
based on the speed (i.e. rpms) and the diameter of the centrifuge. In our laboratory, the centrifuge 
has a relatively small diameter reducing the g-force. The 3622g is within the range previously used 
in the laboratory and reliably separates supernatant and RBC pellets. We are confident that the 
hormone analyses conducted in our laboratory minimized the amount of lysed RBC in the samples. 
 
Comment 4 - I'm assuming that animals were deeply anesthetized before cervical dislocation.  This 
point should be added to the methods where cervical dislocation is mentioned. 
Response 4 – Female hamster used in the oestrus study were deeply anesthetized with isofluorane 
vapours (see lines: 102-104). This was conducted as we collected blood samples from the 
retroorbital sinus. We understand the Reviewers concern that other hamsters were not anesthetized 
before cervical dislocation. We anticipate that the Reviewer may not be familiar with ethical review 
procedures in the UK. The Home Office (UK Government) has outlined and maintains oversight 
over the procedures for the ethical treatment of research animals (i.e. Animal Scientific Procedures 
Point-by Point Rebuttal
Act 1986; Amended in 2002). In the document, a Schedule 1 method for approved euthanasia 
requires animals are killed by cervical dislocation. Only in conditions justified by scientific 
rationale (i.e. hormone sampling) are anaesthesia procedures approved before cervical dislocation.  
 
Comment 5 - The testes are quite porous when sectioned and vulnerable to erroneous labeling using 
IHC.  It would provide more confidence in the findings to have an LD and SD testis labeled with 
the antibody preadsorbed with the antigen.   It's possible that necrotic SD testis tissue shows more 
non-specific labeling, necessitating the labeling of both LD and SD tissues with preadsorbed 
antibody. 
Response 5 – We agree with the Reviewers concern. We have conducted four different ICC 
controls: with no primary antibody, no secondary antibody, no fluorescein and a dose-dependent 
response to pre-adsorption with a blocking peptide. Immmunoreactive signal was abolished when 
the primary, secondary or fluorscein was removed from the protocol. We conducted the 
preadsortion using either 5ug or 10ug of blocking peptide that targets the antibody sequence. Both 
concentrations significantly reduced (p<0.05 and p<0.001 respectively) the immunoreactive signal 
in testes. These data indicate that the DNMT3a antibody used in our analyses has a very high 
specificity for the endogenous DNMT3a protein expression. We have added the control assay to the 
method section (see lines: 181-186). 
 
Comment 6 - It's possible that the negative results for ovarian methylation/dnmt expression result 
from the fact that LD females were not staged in this portion of the experiment in the same manner 
as they were for measuring cyclic changes.  If the SD ovaries are compared to proestrus female 
ovaries, does a difference emerge?  Basically, it's surprising that there are such pronounced changes 
across the cycle (and by E2P4 treatment), yet comparing SD animals with low E2P4 to LD animals 
does not show a difference.  At the minimum, these points should be considered in the discussion. 
Response 6 – We are not completely clear what the Reviewer is asking in this concern. It seems 
there is some mis-interpretation of the results; ovarian methylation was only assessed in the first 
study; and not across the oestrus study as indicated by the Reviewer. Because we did not detect a 
significant different in any measures, such as global methylation or methyltransferase, we opted to 
not investigate ovarian methylation in the oestrus study. It seems the Reviewer may have confused 
the uterine analyses in the oestrus study as ovarian analyses. In hindsight it would have been 
beneficial to collect the ovarian tissues to directly address the Reviewer’s question of whether DNA 
methylation in the ovary changes across the female cycle. Unfortunately, we cannot examine the 
relationship proposed by the Reviewer at this time. However, we predict that any variation in 
ovarian methylation across the oestrus study would be extremely small, if present. In light of the 
robust increase in uterine dnmt3a between LD-SD; compared to the relatively smaller difference in 
uterine dnmt3a across the oestrus cycle, it is unlikely that a statistical difference would be detected 
for dnmt3a in the ovaries. 
 
Reviewer #2:  
Comment 1 - The Short Day (SD) acronym should be included earlier in the Abstract 
Response 1 – We have included the SD acronym earlier in the revised Abstract.  
 
Comment 2 - Line 64: delete 'and' after regulate 
Response 2 – We have deleted ‘and’ accordingly. 
 
Comment 3 - Line 72: include 'and cell culture' after 'uterine tissue' 
Response 3 – We agree with the Reviewer that the cell cultures should be included in this sentence. 
Given the revised organization of the results, we have opted to state ‘cell culture’ after ‘uterine 
tissue’. The sentence now states (see lines: 72-73): ‘Here, we investigated the photoperiod and 
hormonal regulation of gonadal DNA methylation and dnmt1, dnmt3a and dnmt3b expression in 
testicular, ovarian and uterine tissue and cell culture’. 
 Comment 4 - Line 135: More details of the cell line should be provided. In particular, it should be 
made clear that these cells are derived from human non-reproductive tissue (kidney) and why 
hamster cell lines couldn't be used; in the Discussion it should be made clear that extrapolation from 
these cells to in vivo reproductive tissues in rodents should be made with caution. 
Response 4 – We agree with the Reviewer that hamster cells, such as the Chinese hamster ovary 
(CHO), could have been a suitable model. Once we observed the complete lack of photoperiodic 
change in global DNA methylation and DNA methyltransferases (dnmt), CHO cells were clearly 
inappropriate to investigate the role of melatonin for the regulation of dnmt expression. HEK293 
cells were selected because they express all the key players; such as the melatonin receptor 1 
(Conway et al., 1997; new citation #27) and dnmt enzymes. We have added the rationale for using 
HEK293 cells in the methods (see lines: 189-193) and a sentence in the discussion that states 
melatonin driven methylation in HEK293 should be interpreted with caution when extrapolating to 
other cells and animals (see lines: 334-336). 
 
Comment 5 - The quantitative PCR analyses only employed one housekeeping gene (Gapdh). It is 
best practice to use a number (at least two) housekeeping genes whose expression is highly 
correlated for normalisation purposes to ensure that data aren't confounded by effects of the 
experimental manipulations on Gapdh expression.  
Response 5 – We agree with the Reviewer that additional reference genes should be used to assess 
RNA expression. We had initially conducted qPCR for ribosomal 18s (18s) in a subset of tissues 
and observed a very high correlation with gapdh (r=.94). In order to address this concern, we have 
conducted 18s qPCR for all experiments (see lines 161). We used the average CT of gapdh and 18s 
for calculating the Fold expression. qPCR analyses have been revised with the new results. The 
addition of the 18s did not impact the narrative of the findings or eliminate the significance of the 
results. Undoubtedly, there have been some slight modifications to F-values and p-values; however, 
the overall outcome of photoperiod, estrogen and melatonin driven changes in dnmt3a remains. 
 
Comment 6 - The authors should explain why histological analyses were only performed in testes, 
and not in uterus/ovary tissue 
Response 6 – Given the lack of photoperiodic variation in DNA methylation within the ovaries and 
the well defined localization of DNMT3a in the endometrium layer in the uterus, we opted to focus 
on identifying the specific cell types in the testes. We have added a supplementary figure (FigS3) 
from LD and SD uterine tissue to illustrate the robust change in DNMT3a expression. Uterine tissue 
was stained for the DNMT3a (FigS3 G,H) antibody and compared to sections stained with 
hematoxylin and eosin. DNMT3a immunoreactivity shows a clear increase in the SD endometrium.  
 
Comment 7 - Lines 201-202: method of testing for normality should be included 
Response 7 – We have revised the sentence and included the normality test used. The text now 
states: ‘Shapiro-Wilk Normality tests were conducted on all data sets to ascertain whether 
parametric or non-parametric analyses were appropriate’ (see lines: 210-212). 
 
Comment 8 - Line 205: 'mass' should be included after 'testes' 
Response 8 – The section on ‘Statistical analyses’ was revised and this concern was incorporated 
(see lines: 210-212) specifically: ‘T-test was conducted to examine photoperiod effects on testes, 
ovarian and uterine mass as well as global DNA methylation and DNA methyltransferase 
expression.’ 
 
Comment 9 - Line 215: Dnmt3b expression increases ~2-fold rather than ~0.5-fold 
Response 9 – In response to Reviewer 1, we have completely revised the results and separate 
testicular and ovarian data. In the revised section, we have not included a statement on the fold 
change in dnmt3b expression. 
 Comment 10 - Lines 218-220: data should be presented 'per unit volume' rather than simply as 
number of cells 
Response 10 – The Reviewer is correct and we appreciate the notification of our oversight. The 
number of DNMT3a cells was summed across 10 seminiferous tubules and the average for each 
photoperiodic treatment is presented in Fig2B. In the interest of clarity, we have not included the 
unit volume on the y-axis. Instead we have included the per unit volume in the methods section as 
well as the figure legend. See lines: 179-180.  
 
Comment 11 - Lines 221-228: Expression data might be included for an additional few genes to 
show whether melatonin-induced increase, or estrus cycle changes, in Dnmt3a/b expression are 
specific, or due to a general up-regulation of transcription e.g. Dnmt1, genes adjacent to 
Dnmt3a/3b, other genes involved in methylation processes such as Mecp2 
Response 11 – We appreciate the Reviewer’s concern that dnmt3a/b expression may represent a 
general up-regulation of transcription. However, existing data indicates that this is not the case. For 
example, photoperiod treatment did not affect the reference gene CT (p=0.52); indicating that there 
was not a general up-regulation of transcription. Moreover, dnmt1 expression does not consistently 
change with dnmt3a expression, indicating a level of dissociation between the activation of gene 
transcription for the respective DNA methyltransferases. Given these two patterns, we feel the 
additional analyses of general (e.g. reference genes) or methylation genes (e.g. MeCP2) are not 
warranted. 
 
Comment 12 - Lines 230-232: authors need to explain why DNA methylation in uterus was not 
examined. 
Response 12 – We agree that it would be beneficial to confirm that SD uterine tissue exhibits a 
significant increase in global DNA methylation (and across the oestrus cycle [comment 14 below]; 
and driven by E2P4). Unfortunately, the cost for these assays is currently prohibitive. It would 
require additional animals and consumables to conduct the global DNA methylation assay that are 
presently not available. Given the robust photoperiodic change in the testes that is paralleled by the 
change in the uterus, it is likely that global DNA methylation increases in the SD uterine, oestrus 
and in response to E2P4. In addition to the other control studies were have conducted (e.g. uterine 
DNMT3a histology in LD/SD) that confirm the photoperiodic switch in DNA methylation, we feel 
that this addition work is not necessary. We have provided a sentence in discussion that highlights 
the importance of confirming global DNA methylation in the uterus; in addition to employing other 
methods (i.e. ChIP) (see lines 358-360). 
 
Comment 13 - Line 242: change 'slight' to 'slightly' 
Response 13 – The text has been changed accordingly.  
 
Comment 14 - Lines 244-248: Need to clarify that expression data are from uterine tissue; reasons 
for not examining DNA methylation across estrus cycle need to be provided 
Response 14 – A similar concern was raised above (i.e. Comment 12) and a response has been 
provided there.  
 
Comment 15 - Figs 1 and 5B: need to indicate clearly which pairwise comparisons are significant 
Response 15 – The results and figures have been significantly revised to address Comment 1 raised 
by Reviewer 1. In the revised analyses, we have conducted pairwise comparisons and these are 
indicated in the revised Figures. 
 
Comment 16 - Fig 1: Tissues (testes and ovary) need to be included on the x-axis. y-axis should be 
labelled 'relative dnmt1 expression' etc. Often, with the delta delta Ct method, one control group is 
assigned an arbitrary value of 1; perhaps this could be done considered here to make reading fold 
changes in expression easier to determine.  
Response 16 – Similar to response 15; we have considerably revised the organization of the results 
to accommodate suggestions by Reviewer 1. The revised manuscript has addressed the concerns 
raised here. In the interest of clarity, we have kept the y-axis as ‘dnmt expression’. We have used 
‘relative expression’ when discussing the patterns of dnmt in the figure legends. 
 
Comment 17 - The wide age range of the experimental animals might be commented upon; 
presumably reproductive function and success varies considerably between the ages of 3 and 8 
months 
Response 17 – We have selected the age range because hamsters are considered ‘adults’ between 
the ages of 3-9 months. Reproductive senescence, particularly in females, does not occur until 9 
months (at the earliest). It is common to maintain animals in long day conditions without detectable 
changes in reproductive function for over 12 months (e.g. Stevenson & Prendergast, 2013 PNAS). 
We have added a sentence in the methods that supports the age range selected for investigations. 
Specifically, lines: 83-85 state ‘Adulthood in hamsters occurs between the age of 3-9m months (15). 
Hamsters are classified as aged at 14 months (16) and reproductive decline does not occur in 
females until after 9 months (15)’. 
 
Reviewer #3:  
Comment 1 - The animals used appear to live permanently before experimenting with long 
photoperiod condition. However, this species is in nature subjected to photoperiod changes. So is it 
possible to consider that animals used have normal physiology? 
Response 1 – The photoperiodic conditions and age range used in this study is common for 
investigations of seasonal changes in reproductive physiology. It is common to be exposed to LD 
photoperiod for up to 1 year without significant effect to testicular volume/mass or reproduction 
function (e.g. 7). Moreover, aging and reproductive function has been examined in Siberian 
hamsters (15,16). Specifically, Horton & Yellon (2001; citation 15) demonstrated that it takes over 
9 months for reproductive function to decline, even in constant photoperiodic conditions. Therefore, 
the photoperiodic conditions selected for this experiment are entirely suitable to assess normal 
physiology. We have added a sentence in the methods section that addresses this concern. Please 
see lines 83:85.  
 
Comment 2 - Figure 1B shows a 4 fold variation of global methylation in male. This variation is 
very significant for DNA methylation. To consolidate this result, the authors should confirm it 
using another technology. 
Response 2 – We feel that the additional measures including dnmt3a and DNMT3b in testicular 
tissue and the examination of dnmt3a across three other studies in females is sufficient to support 
the marked change in global DNA methylation in reproductive tissues (i.e. testes). Indeed 
Chromatin Immunoprecipitation assays for MeCP2 and/or sodium bisulfite sequencing of DNA 
would provide an alternative method; however, these approaches are not financially feasible at the 
current time. We have included a statement that indicates other methods should be conducted to 
confirm the variation in global methylation (see lines 358-360). 
 
Comment 3 - The staining difference observed between figure 2C and 2D is highly visible. 
However, could this observation be the result of the changes of the organization of the testes. It is 
clear that the size and shape of the seminiferous tubules are not similar. Authors should also take 
the opportunity to identify the type of cell that expresses Dnmt3a. 
Response 3 – We agree with the reviewer that the seminiferous tubules exhibit marked 
morphological changes; these include a massive reduction in the lumen and a decrease in the 
number of sertoli cells and spermatogonia (Type A and B) (see Meachem et al., 2005; Bio Reprod). 
Previous work has illustrated that dnmt3a is localized in the spermatogonia (see citation 12). In 
order to confirm the cells that exhibit DNMT3a expression, we conducted hematoxylin and eosin 
stain of testes sections (See new Fig S2). It appears that in hamsters, DNMT3a is expressed in the 
leydig cells in both LD and SD conditions. However, the increased DNMT3a in SD appears to 
occur in the spermatogonium layer, consistent with the previous identified anatomical localization 
in testes (12).   
 
Comment 4 - The use of melatonin is relevant. However, it is necessary to justify the move to an ex 
vivo model (the cells HEK293) and not to continue the analysis in vivo. 
Response 4 – We agree with the Reviewer and have added a couple sentences in the methods 
section that justify the move to ex vivo model and the choice for HEK293 cells. The text now states 
(see lines 334-336): In order to assess the potential direct effects of melatonin on dnmt3a and 
dnmt3b expression, we conducted a melatonin dose-dependent study using cell culture. Given the 
low levels of DNA methylation and absence of dnmt3a/3b plasticity in the ovary (see results below) 
we selected HEK293 to examine the role of melatonin dependent regulation of dnmt expression as 
these cells are known to express melatonin receptor 1a (27). 
 
Comment 5 - In the discussion lane 287 to 290, the observations made with CONSITE are too 
speculative to be specified using "indicates that it is likely". It is only one track to test 
experimentally. The authors should consider removing this part or perform the experiments 
suggesting that their hypothesis is true. 
Response 5 – We have removed the text from the discussion. 
 
Comment 6 - In the conclusion, the authors indicate that the data have direct applications to human 
fertility. It may be a bit exaggerated given the results. 
Response 6 – We have removed the text from the discussion. 
 
Comment 7 - The presentation of results in the abstract is poorly organized. 
Response 7 – A similar concern was raised by Reviewer 1 above. We have considerably revised the 
abstract with a focus on reorganization of the results. 
 
Comment 8 - Figure 1A and 2A seem very similar. It is not clear what is the difference between the 
two results. 
Response 8 – Figure 1A and 2A both depict photoperiodic regulation in testes mass from two 
different studies. Figure 1A shows SD induce gonadal involution and these testes were used for the 
dnmt1, 3a and 3b expression analyses (Fig1B-D). Figure 2A is a separate group of males (see lines 
xxx) that were used to provide confirmation that SD induced gonadal involution. These testes were 
used for the DNMT3a histology (Fig 2C,D). 
 
Comment 9 - In figure 1C, the expression of dnmt1 slightly decreases in male. Is it possible to reach 
significance by increasing the number of samples? 
Response 9 – In the revised results, the t-test revealed that SD significantly reduced dnmt1 
expression (see new FigS1a). This observation has likely developed from the addition of the second 
reference gene as recommended by Reviewer 2 (see comment #2 above). 
 
Comment 10 - In figure 5, the authors should clarify in the legends, the meaning of white bars, gray 
bars and black bars. 
Response 10 – We thank the Reviewer for this suggestion and we agree this would increase the 
clarity of the figure legend. The text now includes the distinction between white, gray and black 
bars. We have also indicated what the bars represent in Figure 6. 
 
Comment 11 - There is no figure legend for supplementary figure 1. 
Response 11 – We apologise for this oversight. Figure legends have been added to all 
supplementary figures. 
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Abstract 28 
 It is becoming clear that epigenetic modifications such as DNA methylation can be dynamic and in 29 
many cases, reversible. Here, we investigated the photoperiod and hormone regulation of DNA methylation in 30 
testes, ovaries and uterine tissue across multiple time scales. We hypothesized that DNA methyltransferase 3a 31 
(dnmt3a) is driven by photoperiodic treatment, exhibits natural variation across the female reproductive cycle 32 
and that melatonin increases whereas estrogen reduces DNA methylation. We used Siberian hamsters (Phodopus 33 
sungorus) due to their robust changes in reproductive physiology across seasonal and oestrus time scales. Our 34 
findings indicate that short day (SD) – winter like conditions significantly increased global DNA methylation 35 
and dnmt3a expression in the testes. Using immunohistochemistry, we confirm that increased dnmt3a expression 36 
was primarily localized to spermatogonium. Conversely, the ovaries did not exhibit variation in DNA 37 
methylation or dnmt3a/3b expression. However, exposure to SD significantly increased uterine dnmt3a 38 
expression. We then determined that dnmt3a was significantly decreased during the oestrus stage. Next, we 39 
ovariectomized females and subsequently identified that a single estrogen+progesterone injection was sufficient 40 
to rapidly inhibit dnmt3a and dnmt3b expression. Finally, we demonstrate that treatment of HEK293 cells with 41 
melatonin significantly increased both dnmt3a and dnmt3b expression suggesting that long-duration nocturnal 42 
signalling in SD may be involved in the regulation of DNA methylation in both sexes. Overall, our data indicate 43 
that dnmt3a shows marked photoperiod and oestrus plasticity that likely has broad downstream effects on the 44 
timing of the genomic control of reproductive function. 45 
  46 
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Introduction 47 
Biological rhythms in reproductive physiology are common across vertebrates; from fish and reptiles to 48 
bird and mammalian species (1-3). Our understanding of a role for epigenetic modifications, such as DNA 49 
methylation, in regulating biological rhythms is in its infancy. Daily rhythms in metabolism and food intake are 50 
strongly associated with cyclical changes in histone acetylation (4,5).  Moreover, daily changes in the amount of 51 
DNA methylation in a number of gene promoter regions are involved in timing circadian locomotor behavior 52 
(6). Despite these advances, the role of epigenetic rhythms during reproductive cycles is not well described. In 53 
seasonally breeding species such as the Siberian hamster (Phodopus sungorus), the hypothalamus exhibits 54 
photoperiod-dependent reduction in global DNA methylation and enzymes involved in the methylation of DNA 55 
(7). Whether similar changes in DNA methylation occur in the timing of reproductive physiology in peripheral 56 
tissues, such as the testes, ovary and/or uterus, is poorly understood.  57 
 In mammals, the key enzymes that catalyze the methylation of DNA consist of three distinct isoforms: 58 
DNA methyltransferase 1 (dnmt1), 3a (dnmt3a) and 3b (dnmt3b). dnmt1 is critical for maintenance methylation 59 
of DNA during cell division; whereas both dnmt3a and dnmt3b are involved in de novo methylation primarily in 60 
post-meiotic cells (8,9). dnmt1, 3a and 3b enzymes have been identified in testes, ovary and uterine tissue. 61 
dnmt1, dnmt3a and dnmt3b are predominantly localized in the spermatogonia (10), epithelial layer in ovaries 62 
(11) and endometrium cells in the uterus (12). The localization of dnmts in peripheral reproductive tissues 63 
indicates the potential for timing cyclical changes within molecular pathways involved in fertility (13). Indeed 64 
the mechanisms that regulate the functional role of methyltransferases are well described in germline cells and 65 
during development (reviewed by 14). The objective of this paper was to examine photoperiod and hormone 66 
dependent changes in DNA methylation and dnmt1, dnmt3a and dnmt3b mRNA expression in adult testes, ovary 67 
and uterine tissues. 68 
Given the massive seasonal and oestrus changes in testicular and uterine tissue in Siberian hamsters, we 69 
tested the hypotheses that peripheral reproductive tissues exhibit significant variation in global gonadal DNA 70 
methylation and DNA methyltransferase expression. Here, we investigated the photoperiod and hormonal 71 
regulation of gonadal DNA methylation and dnmt1, dnmt3a and dnmt3b expression in testicular, ovarian and 72 
uterine tissue and cell culture. Using adult male and female Siberian hamsters, we identified marked naturally 73 
Lynch et al., 4 
 
occurring plasticity in dnmt3a methyltransferase expression that is regulated by photoperiod, melatonin and 74 
ovarian hormones. Increased dnmt3a in short day (SD) testes results in a substantial accumulation of global 75 
DNA methylation. The findings reported herein reveal robust plasticity in key DNA methylation enzymes and 76 
indicated epigenetic reorganization within peripheral reproductive tissues across multiple time scales. Overall, 77 
this work has significant implications for reproductive timing and fertility in mammalian species. 78 
 79 
Methods 80 
Animals 81 
Adult male and female Siberian hamsters (Total N=100; 3-8 month old) were randomly selected from a 82 
colony maintained at the University of Aberdeen. Adulthood in hamsters occurs between the age of 3-9m 83 
months (15). Hamsters are classified as aged at 14 months (16) and reproductive decline does not occur in 84 
females until after 9 months (15). Hamsters were housed in polypropylene cages in a long day (LD) photoperiod 85 
(15L:9D). Food and water were provided ad libitum and hamsters were provided cotton-nesting material. All 86 
procedures were approved by the Animal Welfare and Ethics Review Board at the University of Aberdeen and 87 
conducted under the Home Office licence (70/7917). 88 
Experimental designs 89 
Photoperiod regulation of reproductive physiology and gonadal DNA methylation 90 
 Thirty-six adult male and female hamsters (3-8 months) were used in this study. Male (n=8) and female 91 
(n=8) hamsters were group housed in long day (15L:9D) conditions prior to the experiment. Baseline measures 92 
of body weight were recorded and measured for the duration of the experiment. A group of males (n=10) and 93 
females (n=10) were transferred from LD to short day cabinets (Arrowmight; SD 9D:15L) for 8 weeks. At the 94 
termination of the study animals were sacrificed by cervical dislocation and testes, ovary and uterine mass was 95 
determined using aeADAM scales (Adam Equipment PGL2002) and measured to ±0.1g. Tissues were frozen in 96 
powdered dry ice and stored at -80°C until global gonadal DNA methylation and RNA expression analyses (see 97 
below). 98 
 99 
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Naturally occurring changes in uterine DNA methyltransferase enzymes across the oestrus cycle 100 
 Female hamsters (N=33) were group housed and maintained in LD. On the final day of the experiment, 101 
animals were sacrificed from 1500-1700 in order to capture the proestrus surge in prolactin (17). Females were 102 
lightly anaesthetized with isofluorane gas (4%) and 500 µl whole blood was collected via the right retro-orbital 103 
sinus using Natelson tubes coated with sodium heparin. The blood samples were kept on ice and then centrifuged 104 
at 9000rpm (3622g) in 4°C for 20 minutes. Plasma was removed and stored at -20°C until prolactin levels were 105 
determined by ELISA assay (see below). Females were sacrificed by cervical dislocation and uterine mass was 106 
measured and subsequently frozen in powdered dry ice. Samples were kept at -80°C until RNA extraction.  107 
Unlike mice and rats, female hamsters do not exhibit marked cyclical changes in vaginal cell types 108 
resulting in the inability for external tracking of the oestrus stages. In order to determine stage of oestrus cycle 109 
we took advantage of a well described method that uses convergent measures consisting of uterine mass and 110 
plasma prolactin concentrations (17). The combinations of reproductive measures permit the identification of 111 
diestrus (low prolactin; small uteri), proestrus (high prolactin; intermediate uteri) and oestrus (low prolactin; 112 
engorged uteri) stages of the female cycle. Plasma prolactin concentrations were determined using a Hamster 113 
Prolactin ELISA (2BScientific Ltd, Oxfordshire, UK). Samples were assayed in duplicate and compared to a 114 
standard curve. The intra-assay coefficient was 4.4%. Analyses of the uterine weight and plasma prolactin values 115 
resulted in the identification of diestrus (n=13), proestrus (n=12) and oestrus (n=8) females. 116 
 117 
The sufficiency of ovarian steroids to regulate DNA methylation enzymes 118 
In order to assess the sufficiency of ovarian hormones on uterine DNA methyltransferase expression, 119 
females were ovariectomized (N=21) and maintained in LD for 8 weeks to reduce circulating levels of gonadal 120 
steroids. In brief, ovariectomies were conducted while hamsters were under deep anaesthesia (5% isofluorane 121 
gas). The ovaries are externalized via bilateral incisions to the dorsum (lateral to the spine, caudal to the 122 
ribcage). The ovary was localized at the distal end of the uterine horn and ligated with sterile sutures (4-0, non- 123 
absorbable monofilament nylon). The ovary was then excised and repeated for the other ovary. The abdominal 124 
wall and skin were closed separately with sterile sutures (5-0 non- absorbable and 4-0 non-absorbable, 125 
respectively; monofilament nylon). After ovariectomy, female body mass decreased on average 7.5g (±0.9 126 
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SEM); a reliable long term indicator of reduced ovarian steroids (18).  Estrogen and progesterone (E2P4) 127 
injections were prepared by dissolving diethylstilbestrol (Sigma Aldrich, UK) and progesterone (Sigma Aldrich, 128 
UK) in sterile vegetable oil to a final concentration of 5μg E2 and 500μg P4 in 100μL vegetable oil (OIL). These 129 
values were selected based on previous work in female hamsters (19). Females received an intraperitoneal 130 
injection at 1700 with 100μl of the hormone cocktail. Control hamsters were injected with 100μl of OIL. The 131 
following day hamsters were sacrificed at 12h (n=6) and 24h (n=6) post-injection by cervical dislocation and 132 
uterine weights were measured and frozen in powdered dry ice. We selected 12hr and 24hr time points to control 133 
for potential daily variation in dnmt3a or dnmt3b expression. OIL controls were counterbalanced across the 12h 134 
and 24h collection periods. 135 
 136 
Assessment of global gonadal DNA methylation 137 
DNA was extracted from tissues using DNeasy kits (QIAGEN, UK) following the manufacturer’s 138 
directions. 1µg of DNA was digested using nuclease P1 (5 units; Sigma Aldrich, UK) and then incubated at 70ºC 139 
for 30 minutes. 1 µl of alkaline phosphatase (5 units; Sigma Aldrich, UK) was added and the samples were 140 
incubated at 37ºC for 30 minutes. The samples were then transferred to 65ºC for 15 min and then placed at -20ºC 141 
until assayed. Global DNA methylation levels were measured using a 5’-methyl-2’-deoxycytidine quantitation 142 
ELISA kit (Cell Biolabs Inc.). The kit is a competitive assay used for the quantification of 5-methyl-2'-143 
deoxycytidine and has previously been used in Siberian hamsters (7). Samples were run in duplicates and the 144 
intra-assay CV was 10%. 145 
 146 
Quantification of RNA expression 147 
RNA was extracted from tissues using Trizol (ThermoFisher Scientific). Nucleic acid concentration and 148 
quality were determined by spectrophotometer (Nanodrop, Thermo Scientific). cDNA was synthesized using 149 
Superscript III (Invitrogen) and cDNA was stored at -20ºC until quantitative PCR was performed. All cDNA 150 
tissue samples were run in triplicate; cDNA from HEK293 cell culture and oestrus study were assayed in 151 
duplicate. qPCRs were performed using a BIORAD CFX96 system using the following steps i) an initial 152 
denature at 95°C for 30 secs, then 39 cycles of ii) 95°C for 10 sec, iii) annealing dependent on target mRNA 153 
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(See Table S1) for 30 secs and then iv) an extension at 72°C for 30 sec. The specificity of select samples was 154 
established by resolving PCR products in 2.5% agarose gel. A melting curve analysis was added to determine the 155 
quality and specificity of each reaction. Quantification of mRNA expression levels was accomplished with iQ 156 
Sybr Green Supermix (BIORAD, UK). We used PCR Miner (22) to calculate reaction efficiencies (E) and cycle 157 
thresholds (CTs). According to the MIQE guidelines, samples that had efficiency values below 0.8 or above 1.2 158 
were excluded from analyses (23). The expression of each target gene of interest was measured in relation the 159 
average cycling time (CT) for two reference targets: glyceraldehyde 3-phosphate dehydrogenase (gapdh 7,24) 160 
and 18S ribosomal RNA (18s; 25) and calculated using 2-(delta-deltaCt). 161 
 162 
Histological analyses of dnmt3a 163 
Male hamsters (n=10) were divided into LD and SD conditions (n=5 each) for 8 weeks. Testes length 164 
and width were measured, weighed and frozen in powdered dry ice. Testes were sectioned at 30 µm with a 165 
cryostat (Reichert-Jung) in series of three. Microscope slides were then placed at -80°C until the 166 
immunocytochemistry (ICC) procedure. Testes sections were washed three times for 5 minutes in 0.1% tween-167 
20 (Sigma-aldrich) in 1M PBS (PBSt). Then tissues were incubated in 3% hydrogen peroxide for 20 minutes 168 
followed by three 5 minute washes in PBSt.  Tissues were incubated in 10nM sodium citrate at 83ºC for 30 169 
minutes followed by three 5 minute washes.  Tissues were then incubated in 5% normal goat serum for 1 h at 170 
room temperature, and then with the DNMT3a primary antibody (PA3-16557, ThermoFisher) at 4ºC for 48 171 
hours. The sections were then washed 3 times, incubated in a biotinyated goat anti-rabbit second antibody 172 
(Vector Labs) for 1 h at room temperature, washed 3 times, incubated in avidin biotin horseradish peroxidase 173 
complex (Vectastain ABC Elite, 1:200) for 1 h, and then washed 3 times.  DNMT3a was visualized by 174 
incubating tissue sections in fluorescein (Vector Labs) for 5 minutes. Sections were then washed 3 times, serially 175 
dehydrated and cover slipped using Vectashield mounting medium with DAPI (Vector Labs).  Sections were 176 
examined using fluorescence light microscopy (Zeiss), and photomicrographs were captured using Zeiss Slide 177 
scanner AxioScan.Z1. Photomicrographs were analysed using ImageJ and cell counts were conducted using 178 
unbiased stereology (26) as previously described (27). The number of DNMT3a cells determined taking the sum 179 
of immunoreactive cells from 10 randomly selected seminiferous tubules for each hamster. 180 
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The specificity of the ICC signal was tested using four controls. We conducted the ICC protocol in the 181 
absence of the primary antibody, no secondary antibody and no fluorescein. In all cases, the immunoreactivity 182 
signal was abolished. Preadsorption of the primary antibody with 5ug or 10ug blocking peptide (3227BP; 183 
Cambridge Bioscience Ltd) for 2 hours resulted in a dose-dependent decrease in staining intensity (p<0.05 and 184 
p<0.001, respectively). Overall, these data indicate that the primary antibody used here is specific for the 185 
endogenous DNMT3a antigen. 186 
 187 
Sufficiency of melatonin to drive DNA methylation enzymes 188 
In order to assess the potential direct effects of melatonin on dnmt3a and dnmt3b expression, we 189 
conducted a melatonin dose-dependent study using cell culture. Given the low levels of DNA methylation and 190 
absence of dnmt3a/3b plasticity in the ovary (see results below) we selected HEK293 to examine the role of 191 
melatonin dependent regulation of dnmt expression as these cells are known to express melatonin receptor 1a 192 
(28). Cells of the HEK293 cell line were grown in Dulbecco’s modified eagle’s medium (DMEM) supplemented 193 
with 10% Fetal bovine serum, 1% Penicillin/Streptomycin and sodium pyruvate (complete medium) in a T75 194 
flask in a humidified atmosphere at 37°C with 5% CO2. HEK293 cells were selected for melatonin assay as these 195 
cells express dnmt3a and dnmt3b as well as the melatonin receptor involved in the neural control of the seasonal 196 
photoperiodic response (20,21). When confluent, HEK293 cells were plated in 24 well plates as follows. Media 197 
was removed and cells were rinsed with Phosphate buffered saline (PBS at 37°C) and 5ml of trypsin was added 198 
to detach cells. 2ml of media was added before pipetting up and down to mix and transferring to a 15ml tube to 199 
pellet cells by centrifugation. Supernatant was removed and cells re-suspended in 7ml complete medium (at 200 
37°C). 150µl of cell suspension (~1x106 cells) was added to each well in a total volume of 1.5ml complete 201 
medium. Cells were allowed to settle for 48 hours in a humidified atmosphere at 37°C with 5% CO2 before 202 
stimulation. In order to examine the sufficiency of melatonin (Sigma Aldrich, UK) to induce RNA expression, 203 
HEK93 cells were assigned to four treatment groups: (1) saline controls; (2) 1nM melatonin (3) 10nM melatonin 204 
or (4) 100nM melatonin. Stimulated cells were incubated for 4 hours in a humidified atmosphere at 37°C with 205 
5% CO2. Wells containing cells and medium were then transferred to -80°C.  206 
 207 
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Statistical analyses 208 
 SigmaStat 13.0 was used for all statistical analyses and significance was determined at p < 0.05. 209 
Shapiro-Wilk Normality tests were conducted on all data sets to ascertain whether parametric or non-parametric 210 
analyses were appropriate. T-test was conducted to examine photoperiod effects on testes, ovarian and uterine 211 
mass as well as global DNA methylation and DNA methyltransferase expression. One-way ANOVA was 212 
conducted to examine the effect of hormone (i.e. E2P4, melatonin) treatment on dnmt expression. Dunnett’s post 213 
hoc analyses were performed to compare hormone treatment versus untreated control conditions. Fishers Least 214 
Square Difference (LSD) was conducted to determine significant difference in uterine mass, plasma prolactin 215 
concentrations and dnmt expression across the oestrus cycle. Log-transformation was conducted on qPCR data 216 
when violations in normality were detected. 217 
 218 
Results 219 
SD induced gonadal involution facilitated testicular DNA methylation 220 
 Exposure to SD significantly reduced testes mass (t=14.33; p<0.001; Fig1a). Regressed testes were 221 
observed to have a robust and significant effect on global DNA methylation levels (t=3.17; p<0.005; Fig1b); 222 
indicating that the timing of testicular involution may be controlled by increased DNA methylation. Next, we 223 
assessed the levels of DNA methyltransferase expression in order to identify the enzymes involved in the 224 
catabolism of increased DNA methylation in regressed testes. dnmt1 expression was found to have significantly 225 
greater levels in LD compared to SD conditions (t=2.77; p<0.01; Fig S1a). Increased dnmt1 in LD testes may be 226 
due to the production of sperm during the breeding periods. dnmt3a expression was observed to exhibit the 227 
predicted increase in SD testes, regressed testes had significantly greater levels compared to LD (t=2.80; p<0.01; 228 
Fig1c). dnmt3b expression was found to remain constant across photoperiodic conditions (t=0.79; p=0.22; 229 
Fig1d). 230 
Regressed testes have more DNMT3a expressing cells 231 
 A t-test was conducted to evaluate the effect of SD on the number of DNMT3a expressing cells in the 232 
testes. SD significantly reduced testes mass (t=9.05; p<0.001; Fig2a). There was a significant increase in the 233 
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number of DNMT3a cells in the SD compared to LD testes (t=2.159; p<0.05; Fig 2b-d). The SD increase in 234 
DNMT3a appears to be localized to spermatogonium (Fig S2). 235 
Ovarian DNA methylation remains constant across photoperiodic conditions. 236 
 Ovary mass showed a relatively small, yet significant decrease in SD compared to LD hamsters (t=2.17; 237 
p<0.05; Fig3a). Unlike the testes, there was no significant photoperiodic effect on ovarian global DNA 238 
methylation (t=0.81; p=0.21; Fig3b). Not surprisingly, there was no significant difference between LD and SD 239 
levels of dnmt1 (t=1.39; p=0.09; FigS1b), dnmt3a (t=0.27; p=0.39; Fig3c) or dnmt3b expression (t=0.62; p<0.27; 240 
Fig3d). 241 
SD significantly increased uterine dnmt3a and dnmt3b 242 
 Exposure to SD significantly reduced uterine mass (t=3.388; P<0.005; Fig4a). Photoperiodic condition 243 
did not significant effect on dnmt1 expression (t=0.95; p<0.18; FigS1c). The decrease in uterine mass was 244 
paralleled by a significant increase in dnmt3a expression (t=3.103; P<0.05; Fig4b) and dnmt3b expression 245 
(t=10.0; P<0.01; Fig4c). Histological analyses indicate that DNMT3a expression in SD shows a robust 246 
immunoreactive signal in the endometrium layer in the uterus (12, FigS3). 247 
dnmt3a expression is reduced during oestrus 248 
 As previously established (Dodge et al., 2002), the oestrus cycle in female hamsters can be determined 249 
using the combined uterine mass and plasma prolactin measures. A one-way ANOVA indicated that uterine 250 
mass exhibits significant variation across the cycle (F=15.623; P<0.001; Fig5a). LSD post-hoc analyses 251 
confirmed that diestrus females have significantly lower uterine mass compared to proestrus (P<0.01) and 252 
oestrus (P<0.001) stages. Furthermore, the uterine mass during oestrus was significantly engorged and greater 253 
compared to proestrus (P<0.005). Plasma prolactin exhibited significant variation across the oestrus cycle 254 
(F=24.202; P<0.001; Fig5a). LSD analyses indicated that plasma prolactin concentrations significantly increased 255 
from diestrus to proestrus (P<0.001). Plasma prolactin concentrations then decreased during the oestrus phase 256 
(P<0.001). Oestrus females were found to have slightly higher levels of plasma prolactin compared to diestrus 257 
females (P<0.05). 258 
 A one-way ANOVA revealed a significant difference in dnmt3a (F=3.53; P<0.05; Fig5b) expression 259 
across the oestrus cycle. LSD analyses indicated that dnmt3a expression significantly decreased during the 260 
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transition from proestrus to oestrus (P=0.01). Diestrus females had intermediate levels as dnmt3a levels were not 261 
significantly different compared to oestrus (P=0.44) or proestrus (P=0.06) hamsters. There was no significant 262 
variation in dnmt3b expression observed across diestrus, proestrus or oestrus phases (F=2.22; P=0.33; Fig5c). 263 
There was no significant change in dnmt1 expression across the oestrus cycle (F=0.26; P=0.77; FigS1d). 264 
E2P4 is sufficient to inhibit DNA methyltransferase expression 265 
 Kruskal-Wallis ANOVA revealed that a single bolus injection of E2P4 was sufficient to significantly 266 
increase uterine mass (H=8.34; p<0.05; Fig6a). Dunnett’s method identified that uterine mass was significantly 267 
greater than OIL treated controls 12hr (p<0.05) and 24hrs (p<0.05) post-injection. These data confirm that E2P4 268 
was capable of inducing engorged uterine and oestrus within 24hrs. A one-way ANOVA revealed a significant 269 
difference in dnmt3a expression after administration of E2P4 (F=13.57; P<0.001; Fig6b). Dunnett’s Method 270 
indicated that E2P4 induced a rapid inhibition in dnmt3a expression with a significant reduction after 12hr 271 
(P<0.001) and 24hr (P<0.001) compared to OIL treated females. Similarly, there was a significant difference in 272 
dnmt3b across treatment groups (F=32.35; P<0.001; Fig6c). E2P4 significantly reduced dnmt3b expression in 273 
uterine tissue 12hr (P<0.001) and 24hrs (P<0.001) after administration. dnmt1 expression was also found to be 274 
significantly reduced by E2P4 treatment (F=8.79; P<0.005; FigS1e). Dunnett’s method revealed that dnmt1 275 
expression was significantly lower 24hr after injection (P<0.005), but not 12hrs (P=0.51). 276 
Melatonin is sufficient to increase dnmt3a and dnmt3b 277 
 Melatonin treatments categorically increased dnmt3a and dnmt3b expression in HEK293 cells. A one-278 
way ANOVA revealed a significant difference in dnmt3a expression across treatment groups (F=17.207; 279 
P<0.001; Fig7a). Dunnett’s Method for post-hoc analyses established that all doses of melatonin induced a 280 
significant increase in dnmt3a compared to control cells (P<0.001), but dnmt3a expression was similar across all 281 
melatonin concentrations (P>0.05). Similarly, the one-way ANOVA revealed a significant difference in dnmt3b 282 
expression (F=39.207; P<0.001; Fig7b). All doses of melatonin were observed to have significantly greater 283 
dnmt3b expression compared to controls (P<0.001). 284 
 285 
Discussion 286 
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 In this paper, we show marked photoperiod dependent regulation of DNA methylation in testes. The 287 
increased methylation appears to be driven by dnmt3a and likely dnmt3b, albeit to a lesser extent. One potential 288 
driver for the short day induced increase in DNA methylation may be a lengthening of nocturnal melatonin 289 
duration. Incubation of HEK293 cells with various concentrations of melatonin was sufficient to elicit a 290 
categorical increase in both dnmt3a and dnmt3b expression. Surprisingly, the ovary failed to show photoperiodic 291 
variation in DNA methylation, indicating a marked gonadal difference in the role of DNA methylation across the 292 
seasonal reproductive cycle. Instead, seasonal variation in DNA methylation may act in the uterus for 293 
reproductive timing. Further examination of dnmt3a and dnmt3b expression revealed significant plasticity during 294 
the oestrus cycle, with inhibition during the oestrus stage due to the increased secretion of oestrogen and 295 
progesterone. We conclude that seasonal and oestrus variation in testicular and uterine dnmt3a expression 296 
enhanced DNA methylation, triggered reproductive involution and reduced fertility. 297 
 Cyclical patterns in epigenetic modifications are gradually being uncovered. Recent work has identified 298 
marked daily (6) and seasonal (7) changes in DNA methylation. In the hypothalamus, there is a decrease in 299 
global DNA methylation and dnmt3b expression in adult Siberian hamsters after prolonged exposure to SD 300 
compared to LD (7). Here we show SD stimulated an increase in DNA methylation and dnmt3a and dnmt3b 301 
expression in peripheral tissues (i.e. testes and uterus). These findings suggest that DNA methylation patterns 302 
show opposite cyclic changes in the central nervous system (7) compared to peripheral systems, such as 303 
reproductive tissue and immune cells (23). DNMT expression in the brain is widely distributed and located in 304 
several hypothalamic nuclei (7). Peripheral tissues (e.g. testes, ovary) consist of a relatively homogenous cell 305 
population compared to the complex networks and diverse cells located in the hypothalamus. The increased 306 
DNMT expression in LD hypothalamus likely reflects the outcome of multiple localized changes and not the 307 
result of a single brain region. A greater resolution of anatomically localized changes in DNMT expression in the 308 
hypothalamus will help resolve the opposite patterns observed in neuroendocrine nuclei and peripheral 309 
reproductive tissues. It is clear that melatonin and ovarian hormones are involved in the regulation of dnmt3a 310 
and dnmt3b expression. Given the categorical increase in dnmt3a and dnmt3b after exposure to melatonin and 311 
the rapid change in response to a single bolus of E2P4, it is likely that these hormones could be acting directly on 312 
promoter regions or in the recruitment of transcription binding factors. Altered hormonal regulation of cell 313 
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autonomous timing of DNA methylation may be one potential molecular mechanism that underlies seasonal 314 
disruption in animal health (29). 315 
 Epigenetic modifications during gamete development are well described (30). Conditional knockout 316 
dnmt3a mice exhibit severe reproductive deficits; males exhibit impaired spermatogenesis and lack DNA 317 
methylation in parentally imprinted genomic regions (31). In females, conditional knockouts of dnmt3a are lethal 318 
and also have an absence of DNA methylation at parentally imprinted genomic regions (31). These data support 319 
a model in which dnmt3a signalling in males and females is vital for the generation of viable gametes and 320 
ultimately, fertility. In our study, we observed relatively low levels of dnmt3a in testes and ovaries in LD 321 
compared to non-breeding, SD conditions. The increase in dnmt3a expression in the regressed testes likely 322 
provides an inhibitory signal that arrests spermatogenesis. Whether enhanced melatonin or reduced gonadal 323 
steroids (i.e. E2P4) provide a hormonal signal that permits the greater dnmt3a expression requires further 324 
exploration. Regardless, the molecular outcome was a massive increase in DNA methylation that results in broad 325 
methylation across the entire genome resulting in reproductive involution. Given that the seasonal pattern in 326 
DNA methylation occurs over multiple annual oscillations, we propose that cyclical DNA methylation in 327 
reproductive tissues provides a single trigger with broad implications for the timing of gene transcription that 328 
enables yearly switches in gamete development and fertility. 329 
 DNMT3a/b has a high enzymatic activity and can rapidly methylate cytosine residues (e.g. 3hrs; 32). In 330 
this paper, we have shown that melatonin can increase dnmt3a and dnmt3b expression in cell culture within 4hrs 331 
and a single bolus of E2P4 can inhibit uterine levels within 12hrs. These data indicate that key seasonal and 332 
reproductive hormones can have a significant impact on dnmt3a/b expression and ultimately lead to a lasting-333 
effect on the epigenomic landscape. It is important to note that caution should be exercised when extrapolating 334 
the melatonin-dependent increase of dnmt3a/b in HEK293 results to seasonal regulation of DNA methylation in 335 
hamster reproductive tissues. Given the large variation in gene transcription during spermatogenesis (33); 336 
seasonal and oestrus patterns in dnmt3a likely function to secure the inhibition of select genes leading to the 337 
successful timing of RNA expression required for optimal fertility. It is likely that several other hormones with 338 
links to reproduction function (e.g. leptin) will also impact the probability of dnmt3a/b expression. Overall, the 339 
rapid and long-term effects of melatonin and ovarian steroids reveal a novel and robust effect on 340 
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methyltransferase expression and illustrate that hormone driven changes in the epigenomic landscape are 341 
probably more common than previously thought. 342 
The comparison of ovarian and testicular DNA methylation permitted the identification of significant 343 
sex differences in the levels of dnmt1 and dnmt3a expression. The higher levels of dnmt1 expression in testes is 344 
likely attributable to gamete production (i.e. spermatogenesis; 34). Several testicular genes exhibit reversible, 345 
seasonal variation in expression and these changes are proposed to enhance fertility during the breeding periods 346 
(35). Since seasonal variations in sperm parameters are common across mammalian species, including humans, 347 
(36,37) the patterns in dnmt1 and dnmt3a may represent an evolutionarily ancient molecular signalling 348 
mechanism for the timing of reproduction. A role for dnmt1 in the timing of reproductive physiology in the 349 
uterus is less clear (FigS1). dnmt3a has been shown to be important for decidualization, exhibiting transient 350 
estrogen-dependent decrease (38). Similarly, we found that E2P4 significantly reduced dnmt3a and dnmt3b. The 351 
specific role of reduced dnmt3a during decidualization is unknown; but may permit stromal vascularity and/or 352 
glandular epithelial secretion. 353 
 In conclusion, we present novel and robust findings that dnmt3a expression is dynamic and propose that 354 
variation in dnmt3a is involved in the local timing of reproductive physiology in key tissues. These data have 355 
significant implications for our understanding of the potential effects of DNA methylation for fertility in a rodent 356 
species. One particularly important finding was the significant increase in global DNA methylation in the male 357 
testes during reproductive involution. Future work that includes alternative methods, such as chromatin 358 
immunoprecipitation for DNMT3a will be important to confirm the large photoperiodic variation in DNA 359 
methylation and identify the genomic regions targeted in both testicular and uterine tissue. Uncovering the 360 
mechanism that underlies this natural pattern could have a significant impact for developing alternative methods 361 
for contraceptives. Moreover, these data provide further evidence that epigenetic modifications exhibit dynamic 362 
and cyclical patterns in expression and indicate DNA methylation is a key characteristic of timing biological 363 
rhythms. 364 
 365 
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 466 
Figure Legends 467 
Figure 1 – Photoperiod induced variation in testicular DNA methylation. A) SD significantly reduced testicular 468 
mass in males. B) regressed testes were observed to have a robust increase in global DNA 469 
methylation. C) the photoperiodic induced change in DNA methylation appears to develop from 470 
increased relative expression of dnmt3a and to a lesser extent dnmt3b (D). Significance is depicted by 471 
*** P<0.001; ** P<0.01; * P<0.05. 472 
Lynch et al., 19 
 
 473 
Figure 2 – Short days increase DNMT3a expression in the testes. A) SD significantly reduced testicular mass. B) 474 
the number of DNMT3a expressing cells (summed across 10 seminiferous tubules) in SD regressed 475 
testes exhibited a significant increase compared to LD controls. C) and D) exemplar 476 
photomicrographs of LD and SD DNMT3a expression in testicular tissue. Note the large decrease in 477 
testicular lumen in SD compared to LD samples. White scale bar represents 3mm. 478 
 479 
Figure 3 – Ovarian tissue lacks photoperiod-dependent changes in DNA methylation. A) SD hamsters were 480 
observed to display a slight decrease in ovarian mass. Unlike the testes, the ovary did not exhibit a 481 
significant difference in global DNA methylation (B). Moreover, both dnmt3a (C) and dnmt3b (D) 482 
relative expression remained constant across LD and SD conditions. 483 
 484 
Figure 4 – Photoperiod-induced variation in relative dnmt3a and dnmt3b uterine expression. Female hamsters 485 
transferred to SD exhibit a significant decrease in uterine mass (A). SD uterine had significantly more 486 
relative dnmt3a (B) and dnmt3b (C) expression compared to LD controls. Significance is depicted by 487 
*** P<0.001; ** P<0.01; * P<0.05. 488 
 489 
Figure 5 – Oestrus significantly decreased relative dnmt3a expression. A) combined uterine mass and plasma 490 
prolactin reliably indicate diestrus (DI), proestrus (PRO) and oestrus phases (EST). Uterine mass is 491 
low in diestrus and significantly increased during proestrus and again during oestrus. Plasma prolactin 492 
is low in diestrus, significantly increased during proestrus and then decreases during oestrus. B) the 493 
levels of relative dnmt3a expression are significantly reduced during oestrus. C) there was a non-494 
significant decrease in relative dnmt3b expression during oestrus. White, grey and black bars indicate 495 
DI, PRO and EST stages respectively. Significance is depicted by *** P<0.001; ** P<0.01; * P<0.05. 496 
 497 
Figure 6 – Rapid inhibition of relative dnmt3a and dnmt3b uterine expression. A) Ovariectomized females 498 
treated with a single bolus injection of E2P4 exhibit a significant increase in uterine mass after 24 hrs 499 
compared to OIL treated controls. There was a trend for heavier uterine in females after 12hrs. E2P4 500 
injections significantly reduced both relative dnmt3a (B) and dnmt3b (C) uterine expression. White 501 
bars depict OIL, grey bars depict 12hr and black bars depict 24hr treatment groups. Significance is 502 
depicted by *** P<0.001; * P<0.05. 503 
 504 
Figure 7 – Melatonin is sufficient to stimulate relative dnmt3a and dnmt3b expression. HEK293 cells incubated 505 
for 4 hours with melatonin exhibited a categorical increase in relative dnmt3a (A) and dnmt3b (B) 506 
expression. Since both dnmt3a and dnmt3b displayed a stepwise increase and not a dose dependent 507 
change in response to increased melatonin, it is likely that melatonin is acting indirectly via other 508 
genomic/molecular pathways. Significance is depicted by *** P<0.001. 509 
 510 
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